Edarbyclor Approved for Hypertension - MPR
Links shared publicly online about this topic.
- 0total visits
Edarbyclor Approved for Hypertension - MPR
empr.com —
View full resource at empr.com
Tags: Heart, Heart Disease, High Blood Pressure, FDA, Cardiology
Most Recently Shared on December 21, 2011 at 7:02 pm By:
Edarbyclor Approved for #Hypertension http://t.co/27BgJed9 #cardiology #cardiovascular
Weight loss pill Qnexa wins panel vote and awaits approval
news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:08 pm By:
Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine - QualityPoint Technologies
qualitypointtech.net — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to the” View full resource at qualitypointtech.net
Most Recently Shared on March 25, 2012 at 11:00 am By:
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine: The fixed drug combination of aliskiren and aml... http://t.co/3t61fV6F
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine
medicalnewstoday.com — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone h” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2012 at 7:05 am By:
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine http://t.co/LloszBoY #hypertension
Sihuan prepares anti-hypertension drug for clinical trial in China
health.yahoo.net — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical trials in China by the end of 2013.” View full resource at health.yahoo.net
Most Recently Shared on March 12, 2012 at 6:40 am By:
Sihuan prepares anti-hypertension drug for clinical trial in China http://t.co/J4W7FnYX
Sihuan prepares anti-hypertension drug for clinical trial in China
health.yahoo.net — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical trials in China by the end of 2013.” View full resource at health.yahoo.net
Most Recently Shared on March 12, 2012 at 5:50 am By:
Jennifer Ann Grisso Nurse and Active Health Library
Sihuan prepares anti-hypertension drug for clinical trial in China: HONG KONG (Reuters) - Chinese drugmaker Sihu... http://t.co/dpqo6TsY
Sihuan prepares anti-hypertension drug for clinical trial in China | Reuters
reuters.com — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical” View full resource at reuters.com
Most Recently Shared on March 12, 2012 at 5:00 am By:
Sihuan prepares anti-hypertension drug for clinical trial in China: HONG KONG (Reuters) - Chinese ... http://t.co/uslJ66bp #health #news
Sihuan prepares anti-hypertension drug for clinical trial in China | Reuters
reuters.com — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical” View full resource at reuters.com
Most Recently Shared on March 12, 2012 at 4:47 am By:
Sihuan prepares anti-hypertension drug for clinical trial in China: HONG KONG (Reuters) - Chinese drugmaker Sihu... http://t.co/13Uq1i2C
Sihuan prepares anti-hypertension drug for clinical trial in China | Reuters
reuters.com — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical” View full resource at reuters.com
Most Recently Shared on March 12, 2012 at 4:45 am By:
Sihuan prepares anti-hypertension drug for clinical trial in China http://t.co/t6QG9gQO
FDA approves drug combo to treat hypertension
nephrologynews.com — “The drug is a fixed-dose therapy that combimes an angiotensin II receptor blocker (ARB) with the diuretic chlorthalidone in a once-daily, single tablet.” View full resource at nephrologynews.com
Most Recently Shared on December 28, 2011 at 4:22 pm By:
Nephrology News Health News and Nephrology
FDA approves drug combo to treat hypertension http://t.co/qqCthKan
Children With PAH May Benefit From Sildenafil
medicalnewstoday.com — “Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH); however, new research presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2011 at 10:05 am By:
MNT Pediatrics News Pediatrics and Health News
Children With PAH May Benefit From Sildenafil http://t.co/YLI8BfnH #pediatrics
TWYNSTA™ For Controlling Hypertension Approved By Health Canada
medicalnewstoday.com — “Health Canada has approved TWYNSTA™ (telmisartan and amlodipine) for the treatment of mild to moderate essential hypertension (when the cause of high blood pressure is unknown) in individual” View full resource at medicalnewstoday.com
Most Recently Shared on October 7, 2011 at 12:05 pm By:
MNT Drug Approvals Health News
TWYNSTA™ For Controlling Hypertension Approved By Health Canada http://mnt.to/429j #regulatory
CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension
news-medical.net — “CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 1:17 pm By:
CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension: CVRx, Inc., a private ... http://t.co/mER5QQs
Implantable Device May Ease Tough-to-Treat Hypertension - MSN Health - Heart & Cardiovascular
health.msn.com — “But complication rate was relatively high and FDA approval may be years away researchers say” View full resource at health.msn.com
Most Recently Shared on July 27, 2011 at 9:29 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Implantable Device May Ease Tough-to-Treat Hypertension http://ow.ly/1dZpsK
FDA OKs study design on Medtronic product that firm is bullish on
medcitynews.com — “FDA approves study design of Medtronic's hypertension product. Read how the maker of new innovative medical devices can enroll patients for a trial.” View full resource at medcitynews.com
Most Recently Shared on July 12, 2011 at 7:29 pm By:
FDA OKs study design on Medtronic product that firm is bullish on http://bit.ly/qeuHD5
FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension
news-medical.net — “Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.” View full resource at news-medical.net
Most Recently Shared on July 12, 2011 at 6:46 am By:
Stroke News: FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension: Medtronic, ... http://twurl.nl/wwvm6n
Advertisement
